Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Revenue

Chunghwa Chemical Synthesis & Biotech had revenue of 154.47M TWD in the quarter ending September 30, 2025, a decrease of -55.64%. This brings the company's revenue in the last twelve months to 977.79M, down -35.53% year-over-year. In the year 2024, Chunghwa Chemical Synthesis & Biotech had annual revenue of 1.35B, down -35.42%.

• Revenue (ttm): 977.79M
• Revenue Growth: -35.53%
• P/S Ratio: 2.04
• Revenue / Employee: 4.94M
• Employees: 198
• Market Cap: 2.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.35B	-739.07M	-35.42%
Dec 31, 2023	2.09B	-30.70M	-1.45%
Dec 31, 2022	2.12B	182.44M	9.43%
Dec 31, 2021	1.93B	391.11M	25.34%
Dec 31, 2020	1.54B	386.95M	33.45%